Antti Rannikko
Antti Rannikko
HUS Helsinki University hospital and Helsinki University
Verified email at
Cited by
Cited by
MRI-targeted or standard biopsy for prostate-cancer diagnosis
V Kasivisvanathan, AS Rannikko, M Borghi, V Panebianco, LA Mynderse, ...
New England Journal of Medicine 378 (19), 1767-1777, 2018
Active surveillance for low-risk prostate cancer worldwide: the PRIAS study
M Bul, X Zhu, R Valdagni, T Pickles, Y Kakehi, A Rannikko, A Bjartell, ...
European urology 63 (4), 597-603, 2013
Magnetic resonance imaging in active surveillance of prostate cancer: a systematic review
IG Schoots, N Petrides, F Giganti, LP Bokhorst, A Rannikko, L Klotz, ...
European urology 67 (4), 627-636, 2015
Dual role of FoxA1 in androgen receptor binding to chromatin, androgen signalling and prostate cancer
B Sahu, M Laakso, K Ovaska, T Mirtti, J Lundin, A Rannikko, A Sankila, ...
The EMBO journal 30 (19), 3962-3976, 2011
Outcomes of men with screen-detected prostate cancer eligible for active surveillance who were managed expectantly
RCN van den Bergh, S Roemeling, MJ Roobol, G Aus, J Hugosson, ...
European urology 55 (1), 1-8, 2009
A decade of active surveillance in the PRIAS study: an update and evaluation of the criteria used to recommend a switch to active treatment
LP Bokhorst, R Valdagni, A Rannikko, Y Kakehi, T Pickles, CH Bangma, ...
European urology 70 (6), 954-960, 2016
Ontogeny of follicle-stimulating hormone receptor gene expression in the rat testis and ovary
HIT Rannikki A S, Zhang F P
Molecular and Cellular Endocrinology 107 (2), 199-208, 1995
Reporting magnetic resonance imaging in men on active surveillance for prostate cancer: the PRECISE recommendations—a report of a European School of Oncology Task Force
CM Moore, F Giganti, P Albertsen, C Allen, C Bangma, A Briganti, ...
European urology 71 (4), 648-655, 2017
Short‐term outcomes of the prospective multicentre ‘Prostate Cancer Research International: Active Surveillance’study
RCN Van Den Bergh, H Vasarainen, HG Van Der Poel, JJ Vis‐Maters, ...
BJU international 105 (7), 956-962, 2010
Gonadotropin-independent regulation of steroidogenesis in the fetal rat testis
F El-Gehani, FP Zhang, P Pakarinen, A Rannikko, I Huhtaniemi
Biology of reproduction 58 (1), 116-123, 1998
Outcomes of initially expectantly managed patients with low or intermediate risk screen‐detected localized prostate cancer
M Bul, RCN van den Bergh, X Zhu, A Rannikko, H Vasarainen, ...
BJU international 110 (11), 1672-1677, 2012
Active surveillance for prostate cancer: a narrative review of clinical guidelines
SM Bruinsma, CH Bangma, PR Carroll, MS Leapman, A Rannikko, ...
Nature Reviews Urology 13 (3), 151-167, 2016
Metabolomic profiling of extracellular vesicles and alternative normalization methods reveal enriched metabolites and strategies to study prostate cancer-related changes
M Puhka, M Takatalo, ME Nordberg, S Valkonen, J Nandania, M Aatonen, ...
Theranostics 7 (16), 3824, 2017
Systematic knockdown of epigenetic enzymes identifies a novel histone demethylase PHF8 overexpressed in prostate cancer with an impact on cell proliferation, migration and invasion
M Björkman, P Östling, V Härmä, J Virtanen, JP Mpindi, J Rantala, T Mirtti, ...
Oncogene 31 (29), 3444-3456, 2012
Compliance rates with the Prostate Cancer Research International Active Surveillance (PRIAS) protocol and disease reclassification in noncompliers
LP Bokhorst, AR Alberts, A Rannikko, R Valdagni, T Pickles, Y Kakehi, ...
European urology 68 (5), 814-821, 2015
Radical prostatectomy for low-risk prostate cancer following initial active surveillance: results from a prospective observational study
M Bul, X Zhu, A Rannikko, F Staerman, R Valdagni, T Pickles, ...
European urology 62 (2), 195-200, 2012
Tranexamic acid in control of primary hemorrhage during transurethral prostatectomy
A Rannikko, A Pétas, K Taari
Urology 64 (5), 955-958, 2004
Functional characterization of the human FSH receptor with an inactivating Ala189Val mutation
A Rannikko, P Pakarinen, PR Manna, I Beau, M Misrahi, K Aittomäki, ...
Molecular human reproduction 8 (4), 311-317, 2002
Phospholipase PLA2G7, associated with aggressive prostate cancer, promotes prostate cancer cell migration and invasion and is inhibited by statins
P Vainio, L Lehtinen, T Mirtti, M Hilvo, T Seppänen-Laakso, J Virtanen, ...
Oncotarget 2 (12), 1176, 2011
Predictors of unfavourable repeat biopsy results in men participating in a prospective active surveillance program
M Bul, RCN Van Den Bergh, A Rannikko, R Valdagni, T Pickles, ...
European urology 61 (2), 370-377, 2012
The system can't perform the operation now. Try again later.
Articles 1–20